Charlie Brindley
Publications by Year
Research Areas
Spine and Intervertebral Disc Pathology, Diabetes Treatment and Management, Musculoskeletal pain and rehabilitation, Antifungal resistance and susceptibility, Regulation of Appetite and Obesity
Most-Cited Works
- → Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion(2008)169 cited
- → Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent(2020)64 cited
- → RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation(2017)47 cited
- → Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study(2020)44 cited
- → Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420(2011)34 cited
- → Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial(2021)29 cited
- → A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results(2018)3 cited
- → Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration(2024)2 cited
- → Author response for "Safety and Efficacy of an Extended‐Release Peptide YY Analogue for Obesity: a Randomised, Placebo‐Controlled , Phase 1 Trial"(2021)1 cited